Assignee
MAINLINE BIOSCIENCES SHANGHAI CO LTD
CN·2 granted patents·1 pending application·0 citations·filing 2018–2023
Top patents by PatentIndex Score
3 records- 0164US2024082346A1Composition Comprising an Antiviral Agent and a CXCR4 Selective Antagonist and Methods For Using the SameMAINLINE BIOSCIENCES SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0258US11883501B2Selective CXCR4 binding peptide conjugate and methods for making and using the sameMAINLINE BIOSCIENCES SHANGHAI CO LTD·Filed 2021·Granted Jan 30, 2024·0 cites·11 claims
- 0356US11771736B2Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the sameMAINLINE BIOSCIENCES SHANGHAI CO LTD·Filed 2018·Granted Oct 3, 2023·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when MAINLINE BIOSCIENCES SHANGHAI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →